Your seat
Saturday, June 20
12:00 PM UTC
HepatologyProf. Meena Bansal
MD, FAASLD
Professor of Medicine · Mount Sinai Hospital Medical Center · USA
Current Academic/Administrative Positions Professor of Medicine System Chief, Division of Liver Diseases Director, MASLD/MASH Center of Excellence Icahn School of Medicine at Mount Sinai Meena.bansal@msssm.edu Biography After completing Gastroenterology/Hepatology Fellowship at the University of Pennsylvania, Dr. Bansal joined the faculty at Mount Sinai in 2001. She maintained an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV. Concurrently, Dr. Bansal held many leadership roles at Mount Sinai, including the inaugural Transplant Hepatology Fellowship Director, Director of Translational Research for the Liver Diseases Division, Medical Director of all Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she oversaw the generation of increased quality dollars in value-based contracts, created Mount Sinai’s first ambulatory pharmacy program and addressed broad population health needs. Dr. Bansal has also served as the principal investigator for numerous clinical trials and clinical translational investigator-initiated studies in MASH. She launched the Mount Sinai MASLD/MASH Center of Excellence which has enrolled over 1200 patients. In January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System. At a national level, Dr. Bansal served as Secretary (2019-2021) for AASLD and has been elected as Councilor (2027-2032) and will serve as AASLD President in 2031.
Cirrhosis Reversal: The Sprint is Not Over Yet!
For decades, advanced liver cirrhosis was considered a one-way street. Today, we know reversal is possible—but the race to universal therapies is far from finished. This session dives straight into the cutting edge of hepatology, moving past historical dogmas to confront the real-world challenges of advanced vascular remodeling and genetic roadblocks.
What You Will Learn:
The Reality of Regression: Real evidence on how the liver dismantles dense collagen matrix.
Modern Drivers: Practical strategies for managing metabolic dysfunction-associated steatohepatitis (MASH) and viral clearance.The Therapeutic Pipeline: A first look at emerging drugs targeting hepatic stellate cells to halt and reverse deep scarring.
Who Should Attend?
* Hepatologists & Gastroenterologists looking to optimize current patient regression pathways.
* Translational Researchers focused on the next generation of antifibrotic drug targets.
* Healthcare Professionals eager to bridge the gap between clinical trials and bedside care.
Don't miss out on the conversation shaping the future of liver health. Secure your seat today!
Dr. Sanjaya Satapathy
Host
Dr. Meena Bansal
Presenter
Dr. Shivaram Prasad Singh
Panelist
Dr. Prasun K Jalal
Panelist
Dr. Eternity Labio
Panelist
Dr. Kenan Moral
Panelist
Dr. Roxana Bodin
Panelist
Dr. Kavish Patidar
Panelist
Dr. Raj Uchila
Panelist
Dr. Bilal Bobat
Panelist

Dr. Faisal Abaalkhail
Panelist
Dr. Anil Chandra Anand
Panelist
Dr. nipun verma
Panelist
Dr. Hatef Massoumi
Panelist
Dr. Benedict Maliakkal
Panelist
Dr. Suzana Calretas
Panelist
Dr. Iman Montasser
Panelist